Top Markets
Coin of the day
Lobe Sciences Ltd. Lobe Sciences Ltd.

Lobe Sciences Ltd.

LOBE
Classifica tra le azioni #30765
Lobe Sciences Ltd. operates as a life sciences entity, primarily focused on the... Lobe Sciences Ltd. operates as a life sciences entity, primarily focused on the exploration and advancement of psychedelic pharmaceutical compounds. The company is actively engaged in formulating psilocybin-derived therapeutics, combined with N-acetylcysteine, intended for the treatment of mild traumatic brain injuries and post-traumatic stress disorder. Beyond drug development, it also engineers specialized devices designed to facilitate the efficient delivery of various medications. The organization was previously known as Greenstar Biosciences Corp. before formally changing its name to Lobe Sciences Ltd. in November 2020. Its main corporate office is situated in Vancouver, Canada.
Prezzo delle azioni
$0.05504527
Ultima sincronizzazione: 2026-08-17
Capitalizzazione di mercato
$15.64M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
51.92%
Paese
CA
Scambia Lobe Sciences Ltd. (LOBE)

Categoria

Rapporto P/B per Lobe Sciences Ltd. (LOBE)
Rapporto P/B al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Lobe Sciences Ltd., il rapporto P/B attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/B per Lobe Sciences Ltd. da 2026 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
Non abbastanza dati per le date fornite.
Rapporto P/B per aziende simili o concorrenti